Association of psychological, somatic symptoms, adaptive functioning and parental stress in childrn and adolescents with fetal alcohol spectrum disorders (FASD)
Recruiting
- Conditions
- Q86.0Fetal alcohol syndrome (dysmorphic)
- Registration Number
- DRKS00025378
- Lead Sponsor
- Klinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Age 0-17 years, written consent for study participation, sufficient German language knowlede
Exclusion Criteria
Age =/> 18 years, insufficient German language knowlede
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Assessment of FASD diagnostic criteria, psychiatric and somatic diagnoses<br>- psychological symptoms (Strength and Difficulties Questionnaire, SDQ)<br>- adaptive skills (Vineland-3)<br>- parental stress (Elternstressfragebogen, ESF)<br>
- Secondary Outcome Measures
Name Time Method Information about already installed therapies and treatments, supportives programmes for the affected child, gaps in support and therapy, information about biological mothers
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological pathways link prenatal alcohol exposure to psychological and somatic symptoms in FASD (Q86.0) as observed in DRKS00025378?
How do current therapeutic strategies for FASD address comorbid psychological and somatic symptoms compared to observational data?
What potential biomarkers distinguish FASD subtypes (Q86.0) with specific psychological and somatic symptom profiles?
What are the most effective management strategies for somatic and psychological comorbidities in FASD-affected children based on observational studies?
Are there existing pharmacological interventions targeting neurobehavioral deficits in FASD populations compared to observational findings?